04147 C-type lectin 10A as a potential biomarker in acute intermittent porphyria

UV and visible bands, they come with their own range of drawbacks.Compared to their UV counterparts, visible sunscreens are not so widely known, are often not available on the supermarket shelves, and, importantly, are pigmented.This means that a patient must match the pigment of their skin to that of the sunscreen, and given the limited choices available, this can prove difficult from person to person, and even across areas of the body.Furthermore, sunscreen is no guarantee of protection, but rather increases the time allowed until a photosensitive reaction occurs.This will also vary depending on the manner in which the individual has applied the sunscreen; how light or how heavy, in patches, over make up, in wet or dry conditions.Our research brings these issues into focus in a number of areas.Firstly, we have been routinely testing sunscreens of all types using our spectrophotometer in order to analyse their protective qualities, some of which has been previously published (Eadie et al., 2023, doi.org/10.1093/bjd/ljac112).We have found that protection varies from product to product, which is a particular issue for porphyria patients who may have to test multiple products before settling on the best protection for them.Secondly, we have been polling our photosensitive patients to understand more about the role sunscreens play in their photo-protection strategies.Through this type of patient-engagement, we have learned about the value patients place on factors such as cost, availability and application against other photo-protection methods such as sun-avoidance and protective clothing.We are extending this to porphyria patients in conjunction with the British Porphyria Association (BPA) and will present the results of this survey.Thirdly, we have begun building a public-access database of sunscreens with the intention of allowing patients to discover the protective qualities of these products for themselves, whilst comparing them side-by-side.We plan to engage with the BPA to facilitate patient-friendly guidance on photo-protection.

Authors

Institutions

Publication Details

Published
2024-09-01
DOI
https://doi.org/10.1136/bmjgast-2024-icpp.29
Primary Topic
Porphyrin Metabolism and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

04147 C-type lectin 10A as a potential biomarker in acute intermittent porphyria

Bård Ove Karlsen, Elin Storjord, Ole‐Lars Brekke
Porphyrin Metabolism and Disorders
article

04147 C-type lectin 10A as a potential biomarker in acute intermittent porphyria

Bård Ove Karlsen, Elin Storjord, Ole‐Lars Brekke
article en

Abstract

UV and visible bands, they come with their own range of drawbacks.Compared to their UV counterparts, visible sunscreens are not so widely known, are often not available on the supermarket shelves, and, importantly, are pigmented.This means that a patient must match the pigment of their skin to that of the sunscreen, and given the limited choices available, this can prove difficult from person to person, and even across areas of the body.Furthermore, sunscreen is no guarantee of protection, but rather increases the time allowed until a photosensitive reaction occurs.This will also vary depending on the manner in which the individual has applied the sunscreen; how light or how heavy, in patches, over make up, in wet or dry conditions.Our research brings these issues into focus in a number of areas.Firstly, we have been routinely testing sunscreens of all types using our spectrophotometer in order to analyse their protective qualities, some of which has been previously published (Eadie et al., 2023, doi.org/10.1093/bjd/ljac112).We have found that protection varies from product to product, which is a particular issue for porphyria patients who may have to test multiple products before settling on the best protection for them.Secondly, we have been polling our photosensitive patients to understand more about the role sunscreens play in their photo-protection strategies.Through this type of patient-engagement, we have learned about the value patients place on factors such as cost, availability and application against other photo-protection methods such as sun-avoidance and protective clothing.We are extending this to porphyria patients in conjunction with the British Porphyria Association (BPA) and will present the results of this survey.Thirdly, we have begun building a public-access database of sunscreens with the intention of allowing patients to discover the protective qualities of these products for themselves, whilst comparing them side-by-side.We plan to engage with the BPA to facilitate patient-friendly guidance on photo-protection.

Nordland Hospital Trust (NO), UiT The Arctic University of Norway (NO)
Zero hunger
Openalex Percentile: Top 86%
Porphyrin Metabolism and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.